7-36513344-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001637.4(AOAH):āc.1636A>Cā(p.Lys546Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000855 in 1,614,118 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001637.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AOAH | NM_001637.4 | c.1636A>C | p.Lys546Gln | missense_variant | 21/21 | ENST00000617537.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AOAH | ENST00000617537.5 | c.1636A>C | p.Lys546Gln | missense_variant | 21/21 | 1 | NM_001637.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152120Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000837 AC: 21AN: 251022Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135660
GnomAD4 exome AF: 0.0000862 AC: 126AN: 1461880Hom.: 1 Cov.: 33 AF XY: 0.0000866 AC XY: 63AN XY: 727238
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 22, 2024 | The c.1636A>C (p.K546Q) alteration is located in exon 21 (coding exon 21) of the AOAH gene. This alteration results from a A to C substitution at nucleotide position 1636, causing the lysine (K) at amino acid position 546 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at